Previous close | 18.32 |
Open | 18.32 |
Bid | 18.50 |
Ask | 18.80 |
Strike | 25.00 |
Expiry date | 2025-01-17 |
Day's range | 18.32 - 18.32 |
Contract range | N/A |
Volume | |
Open interest | 102 |
NEVE ILAN, Israel, Sept. 13, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced its participation in the Cantor Fitzgerald Global Healthcare Conference 2023, which will be held on September 26-28, 2023 at the InterContinental Barclay Hotel in New York City. Nanox’s Chief Executive Officer, Erez Meltzer, and Chief Financial Officer, Ran Daniel, will engage in a fireside chat and host investor 1x1
Growth stocks have lost momentum in August after a strong start to the year. Innovative companies in the fields of drug development and medical imaging, such as Agenus (NASDAQ: AGEN), BioCryst Pharmaceuticals (NASDAQ: BCRX), and Nano-X Imaging (NASDAQ: NNOX) have all experienced a significant drop in their stock prices in the past 30 days.
Nano-X Imaging ( NASDAQ:NNOX ) Second Quarter 2023 Results Key Financial Results Net loss: US$17.4m (loss narrowed by...